Treatment intensification might not improve survival in high-grade B-cell lymphoma with a concurrent MYC and BCL2 and/or BCL6 rearrangement: A retrospective, multicenter, pooled analysis

Vanja Zeremski; Ellen D. McPhail; Thomas M. Habermann; Francesca Schieppati; Niklas Gebauer; Theodoros P. Vassilakopoulos; Dimitrios Mougiakakos

doi:10.1002/hon.3130

Treatment intensification might not improve survival in high-grade B-cell lymphoma with a concurrent MYC and BCL2 and/or BCL6 rearrangement: A retrospective, multicenter, pooled analysis

Vanja Zeremski, Ellen D. McPhail, Thomas M. Habermann, Francesca Schieppati, Niklas Gebauer, Theodoros P. Vassilakopoulos, Dimitrios Mougiakakos

Hematology

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Journal	Hematological Oncology
DOIs	https://doi.org/10.1002/hon.3130
State	Accepted/In press - 2023

Keywords

double-hit
induction treatment
lymphoma
overall survival
triple-hit

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1002/hon.3130

Cite this

Zeremski, V., McPhail, E. D., Habermann, T. M., Schieppati, F., Gebauer, N., Vassilakopoulos, T. P., & Mougiakakos, D. (Accepted/In press). Treatment intensification might not improve survival in high-grade B-cell lymphoma with a concurrent MYC and BCL2 and/or BCL6 rearrangement: A retrospective, multicenter, pooled analysis. Hematological Oncology. https://doi.org/10.1002/hon.3130

@article{1ab11ebb63ea4672b2685b2f075eefd1,

title = "Treatment intensification might not improve survival in high-grade B-cell lymphoma with a concurrent MYC and BCL2 and/or BCL6 rearrangement: A retrospective, multicenter, pooled analysis",

keywords = "double-hit, induction treatment, lymphoma, overall survival, triple-hit",

author = "Vanja Zeremski and McPhail, {Ellen D.} and Habermann, {Thomas M.} and Francesca Schieppati and Niklas Gebauer and Vassilakopoulos, {Theodoros P.} and Dimitrios Mougiakakos",

note = "Funding Information: Vanja Zeremski was supported by the European School of Oncology through participation on Certificate of Competence in Lymphoma program (2021/2022). ",

year = "2023",

doi = "10.1002/hon.3130",

language = "English (US)",

journal = "Hematological Oncology",

issn = "0278-0232",

publisher = "John Wiley and Sons Ltd",

}

TY - JOUR

T1 - Treatment intensification might not improve survival in high-grade B-cell lymphoma with a concurrent MYC and BCL2 and/or BCL6 rearrangement

T2 - A retrospective, multicenter, pooled analysis

AU - Zeremski, Vanja

AU - McPhail, Ellen D.

AU - Habermann, Thomas M.

AU - Schieppati, Francesca

AU - Gebauer, Niklas

AU - Vassilakopoulos, Theodoros P.

AU - Mougiakakos, Dimitrios

N1 - Funding Information: Vanja Zeremski was supported by the European School of Oncology through participation on Certificate of Competence in Lymphoma program (2021/2022).

PY - 2023

Y1 - 2023

KW - double-hit

KW - induction treatment

KW - lymphoma

KW - overall survival

KW - triple-hit

UR - http://www.scopus.com/inward/record.url?scp=85150886046&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85150886046&partnerID=8YFLogxK

U2 - 10.1002/hon.3130

DO - 10.1002/hon.3130

M3 - Letter

C2 - 36945194

AN - SCOPUS:85150886046

SN - 0278-0232

JO - Hematological Oncology

JF - Hematological Oncology

ER -

Treatment intensification might not improve survival in high-grade B-cell lymphoma with a concurrent MYC and BCL2 and/or BCL6 rearrangement: A retrospective, multicenter, pooled analysis

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this